{"id":1611,"date":"2020-03-10T15:58:26","date_gmt":"2020-03-10T15:58:26","guid":{"rendered":"http:\/\/www.isispharma.com\/?page_id=1611"},"modified":"2024-04-04T09:51:54","modified_gmt":"2024-04-04T09:51:54","slug":"legal-notice","status":"publish","type":"page","link":"https:\/\/www.isispharma.com\/en\/legal-notice\/","title":{"rendered":"Legal Notice"},"content":{"rendered":"<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Publisher <\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">ISISPHARMA FRANCE, SAS with a capital of 42,006 euros, and company headquarters at 29 avenue de la Marne, Parc des 3 Ch\u00eanes &#8211; 59290 WASQUEHAL, France and registered in the Trade Registry of Lille M\u00e9tropole under the number 499.855.013, <\/span><\/p>\n<p>Phone :<span style=\"font-weight: 400;\"> <a href=\"tel:+33428000400\">04 28 00 04 00<\/a><br \/>\n<\/span>Email : <a href=\"mailto:contact@isispharma.com\"><span style=\"font-weight: 400;\">contact@isispharma.com<\/span><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Taxpayer identification number<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">FR 50\u00a0499 8550 13<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Director of publication<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">Gr\u00e9goire Dewavrin.<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Editorial content development<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">ISISPHARMA FRANCE Digital Department<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Hosting<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">OVH, SAS registered in the Trade Registry of\u00a0 Lille-M\u00e9tropole under the number 424.761.419 and headquartered at 2 rue Kellermann &#8211; 59100 ROUBAIX, France.<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Site design<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\"><strong><a href=\"http:\/\/lesanimals.digital\/en\/?utm_source=credit&amp;utm_medium=web&amp;utm_campaign=isipharma\">Les Animals<\/a><br \/>\n<\/strong><\/span><span style=\"font-weight: 400;\">29 rue Ravat \u2014 69002 Lyon, France<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Technical production <\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\"><strong><a href=\"https:\/\/vahumana.fr\/\">Vahumana<\/a><br \/>\n<\/strong>33 rue Maurice Flandin \u2013 69003 Lyon, France.<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Photography credits<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">Les Animals agency.\u00a0<\/span><\/p>\n<div class=\"annotation\">\n<p><span style=\"font-weight: 400;\">Contact us<\/span><\/p>\n<\/div>\n<p><span style=\"font-weight: 400;\">access online contact form <\/span><span style=\"font-weight: 400;\"><a href=\"http:\/\/www.isispharma.com\/en\/contact\/\">here<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">ISISPHARMA FRANCE is a company of the DEWAVRIN COSMETICS Group.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publisher ISISPHARMA FRANCE, SAS with a capital of 42,006 euros, and company headquarters at 29 avenue de la Marne, Parc des 3 Ch\u00eanes &#8211; 59290 WASQUEHAL, France and registered in the Trade Registry of Lille M\u00e9tropole under the number 499.855.013, Phone : 04 28 00 04 00 Email : contact@isispharma.com\u00a0 Taxpayer identification number FR 50\u00a0499 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":868,"parent":0,"menu_order":13,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Legal Notice - Isispharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.isispharma.com\/en\/legal-notice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Legal Notice - Isispharma\" \/>\n<meta property=\"og:description\" content=\"Publisher ISISPHARMA FRANCE, SAS with a capital of 42,006 euros, and company headquarters at 29 avenue de la Marne, Parc des 3 Ch\u00eanes &#8211; 59290 WASQUEHAL, France and registered in the Trade Registry of Lille M\u00e9tropole under the number 499.855.013, Phone : 04 28 00 04 00 Email : contact@isispharma.com\u00a0 Taxpayer identification number FR 50\u00a0499 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.isispharma.com\/en\/legal-notice\/\" \/>\n<meta property=\"og:site_name\" content=\"Isispharma\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-04T09:51:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1950\" \/>\n\t<meta property=\"og:image:height\" content=\"1300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/\",\"url\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/\",\"name\":\"Legal Notice - Isispharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.isispharma.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg\",\"datePublished\":\"2020-03-10T15:58:26+00:00\",\"dateModified\":\"2024-04-04T09:51:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.isispharma.com\/en\/legal-notice\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage\",\"url\":\"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg\",\"contentUrl\":\"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg\",\"width\":1950,\"height\":1300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.isispharma.com\/en\/legal-notice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"type\":\"Thing\",\"id\":\"https:\/\/www.isispharma.com\/en\/\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"type\":\"Thing\",\"id\":\"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages\/1611\/\",\"name\":\"Legal Notice\"}}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.isispharma.com\/en\/#website\",\"url\":\"https:\/\/www.isispharma.com\/en\/\",\"name\":\"Isispharma\",\"description\":\"Dermatologie\",\"publisher\":{\"@id\":\"https:\/\/www.isispharma.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.isispharma.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Legal Notice - Isispharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.isispharma.com\/en\/legal-notice\/","og_locale":"en_US","og_type":"article","og_title":"Legal Notice - Isispharma","og_description":"Publisher ISISPHARMA FRANCE, SAS with a capital of 42,006 euros, and company headquarters at 29 avenue de la Marne, Parc des 3 Ch\u00eanes &#8211; 59290 WASQUEHAL, France and registered in the Trade Registry of Lille M\u00e9tropole under the number 499.855.013, Phone : 04 28 00 04 00 Email : contact@isispharma.com\u00a0 Taxpayer identification number FR 50\u00a0499 [&hellip;]","og_url":"https:\/\/www.isispharma.com\/en\/legal-notice\/","og_site_name":"Isispharma","article_modified_time":"2024-04-04T09:51:54+00:00","og_image":[{"width":1950,"height":1300,"url":"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/","url":"https:\/\/www.isispharma.com\/en\/legal-notice\/","name":"Legal Notice - Isispharma","isPartOf":{"@id":"https:\/\/www.isispharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage"},"image":{"@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage"},"thumbnailUrl":"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg","datePublished":"2020-03-10T15:58:26+00:00","dateModified":"2024-04-04T09:51:54+00:00","breadcrumb":{"@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.isispharma.com\/en\/legal-notice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/#primaryimage","url":"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg","contentUrl":"https:\/\/www.isispharma.com\/wp-content\/uploads\/2020\/02\/mentions.jpg","width":1950,"height":1300},{"@type":"BreadcrumbList","@id":"https:\/\/www.isispharma.com\/en\/legal-notice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"item":{"type":"Thing","id":"https:\/\/www.isispharma.com\/en\/","name":"Accueil"}},{"@type":"ListItem","position":2,"item":{"type":"Thing","id":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages\/1611\/","name":"Legal Notice"}}]},{"@type":"WebSite","@id":"https:\/\/www.isispharma.com\/en\/#website","url":"https:\/\/www.isispharma.com\/en\/","name":"Isispharma","description":"Dermatologie","publisher":{"@id":"https:\/\/www.isispharma.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.isispharma.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages\/1611"}],"collection":[{"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/comments?post=1611"}],"version-history":[{"count":4,"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages\/1611\/revisions"}],"predecessor-version":[{"id":5220,"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/pages\/1611\/revisions\/5220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/media\/868"}],"wp:attachment":[{"href":"https:\/\/www.isispharma.com\/en\/wp-json\/wp\/v2\/media?parent=1611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}